CLINICAL_TRIALS
trial_result
· 2017-12-11
Clinical Trial Update: A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair) [Phase 4]
Summary
This Phase 4 clinical trial evaluated initiating omalizumab (Xolair) in individuals with asthma and has completed, with results posted in December 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2017-12-11